Sato Kentaro, Matsui Shimpei, Takamatsu Manabu, Noguchi Tatsuki, Sakamoto Takashi, Mukai Toshiki, Yamaguchi Tomohiro, Akiyoshi Takashi
Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, Japan.
Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, Japan.
Surg Today. 2025 Mar 28. doi: 10.1007/s00595-025-03031-z.
Few studies have evaluated whether the timing of colectomy affects the prognosis of appendiceal cancer. This study compared long-term outcomes and recurrence patterns between initial appendectomy followed by two-stage colectomy and one-stage colectomy for appendiceal cancer.
We retrospectively evaluated 65 patients who underwent 2-stage (n = 17) or 1-stage (n = 48) right-sided colectomy with lymph node dissection for stage 0-III appendiceal cancer between August 2005 and December 2022. The recurrence types and risk factors were compared.
The 2-stage colectomy group had a more advanced disease stage than the 1-stage group (stage III cases: 29.4% vs. 14.6%, P = 0.03). The 5-year overall recurrence rates were similar between the groups (29.4% vs. 19.2%, P = 0.39). All peritoneal recurrence cases (n = 9) had pT3 or T4 depth. Among pT3 and T4 cases (n = 46), the peritoneal recurrence rates did not differ significantly (31.2% vs. 13.8%, P = 0.17). A multivariate analysis identified preoperative serum CA19-9 level of > 37 ng/mL (hazard ratio [HR], 35.4; 95% confidence interval [CI], 3.08-406.8; P = 0.004) and lymph node metastasis (HR, 42.6; 95% CI, 9.90-183.6; P < 0.001) as independent risk factors for peritoneal recurrence.
Serum CA19-9 levels and lymph node metastasis are risk factors for peritoneal recurrence. The effect of colectomy timing on recurrence was not definitive.
很少有研究评估结肠切除术的时机是否会影响阑尾癌的预后。本研究比较了阑尾癌患者先行阑尾切除术然后二期结肠切除术与一期结肠切除术的长期结局和复发模式。
我们回顾性评估了2005年8月至2022年12月期间因0-III期阑尾癌接受二期(n = 17)或一期(n = 48)右侧结肠切除术并进行淋巴结清扫的65例患者。比较了复发类型和危险因素。
二期结肠切除术组的疾病分期比一期组更晚(III期病例:29.4%对14.6%,P = 0.03)。两组的5年总复发率相似(29.4%对19.2%,P = 0.39)。所有腹膜复发病例(n = 9)均为pT3或T4深度。在pT3和T4病例(n = 46)中,腹膜复发率无显著差异(31.2%对13.8%,P = 0.17)。多因素分析确定术前血清CA19-9水平> 37 ng/mL(风险比[HR],35.4;95%置信区间[CI],3.08-406.8;P = 0.004)和淋巴结转移(HR,42.6;95% CI,9.90-183.6;P < 0.001)为腹膜复发的独立危险因素。
血清CA19-9水平和淋巴结转移是腹膜复发的危险因素。结肠切除术时机对复发的影响不明确。